Unum Therapeutics

Sold for pennies, Unum gets one last shot at redemption
Endpoints
Mon, 08/31/20 - 10:42 am
Unum Therapeutics
cell therapy
Sotio
Unum racks up yet another FDA hold as it twists its way through a restructuring, looking for a fresh start with a preclinical drug
Endpoints
Mon, 03/9/20 - 11:36 pm
Unum Therapeutics
ACTR707
B-cell non-Hodgkin lymphoma
clinical trials
Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies
Xconomy
Thu, 03/29/18 - 09:56 am
Unum Therapeutics
cell therapy
IPOs
Cell therapy flotations could follow Kite and Juno buyouts
EP Vantage
Wed, 03/7/18 - 06:24 pm
cell therapy
Kite Pharma
Juno Therapeutics
M&A
Unum Therapeutics
Autolus
The 2015 Fierce 15 biotech execs take a bow
Fierce Biotech
Sat, 10/3/15 - 02:01 pm
Alector
Arvinas
CRISPR Therapeutics
Intellia Therapeutics
NGM Biopharmaceuticals
Padlock Therapeutics
SQZ Biotech
Revolution Medicines
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Wed, 09/30/15 - 09:51 am
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
Seattle Genetics conjugates with immuno-oncology upstart Unum in $645M deal
Fierce Biotech
Mon, 06/8/15 - 10:53 am
Seattle Genetics
immuno-oncology
Unum Therapeutics